About Enhancer
Enhancer ID: |
E_01_0299 |
Species: |
human |
Position :
|
chr15:99562775-99564775 |
Biosample name: |
|
Experiment class :
|
High+Lowthroughput |
Enhancer type: |
Enhancer |
Disease: |
Mammary cancer |
Pubmed ID: |
30678091
|
Enhancer experiment: |
PCR?Western blot?ChIP-seq |
Enhancer experiment description: |
The strongest effect visible in three distinct cell types was observed for rs12946510 that is predicted to alter MEF2A/C and FOXO1 binding sites. |
About Target gene
Target gene : |
-- |
Strong evidence: |
qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: |
RNA-Seq |
Target gene experiment description: |
The strongest effect visible in three distinct cell types was observed for rs12946510 that is predicted to alter MEF2A/C and FOXO1 binding sites. |
About TF
TF name : |
MEF2A(A430079H05Rik) |
TF experiment: |
PCR?Western blot?ChIP-seq |
TF experiment description: |
The strongest effect visible in three distinct cell types was observed for rs12946510 that is predicted to alter MEF2A/C and FOXO1 binding sites. |
About Function
Enhancer function : |
The strongest effect visible in three distinct cell types was observed for rs12946510 that is predicted to alter MEF2A/C and FOXO1 binding sites. |
Enhancer function experiment: |
Immunohistochemical staining |
Enhancer function experiment description: |
The strongest effect visible in three distinct cell types was observed for rs12946510 that is predicted to alter MEF2A/C and FOXO1 binding sites. |
About SNP
Upstream Pathway Annotation of TF
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene
Expression of target genes for the
enhancer
Enhancer associated SNPs